Kelly DL - Search Results

1

Cervical cancer screening and acute care visits among Medicaid enrollees with mental and substance use disorders.

Abrams MT, Myers CS, Feldman SM, Boddie-Willis C, Park J, McMahon RP, Kelly DL. Abrams MT, et al. Among authors: kelly dl. Psychiatr Serv. 2012 Aug;63(8):815-22. doi: 10.1176/appi.ps.201100301. Psychiatr Serv. 2012. PMID: 22660581 Free PMC article.

2

Comparison of discharge rates and drug costs for patients with schizophrenia treated with risperidone or olanzapine.

Kelly DL, Nelson MW, Love RC, Yu Y, Conley RR. Kelly DL, et al. Psychiatr Serv. 2001 May;52(5):676-8. doi: 10.1176/appi.ps.52.5.676. Psychiatr Serv. 2001. PMID: 11331805

3

Novel factor-based symptom scores in treatment resistant schizophrenia: implications for clinical trials.

McMahon RP, Kelly DL, Kreyenbuhl J, Kirkpatrick B, Love RC, Conley RR. McMahon RP, et al. Among authors: kelly dl. Neuropsychopharmacology. 2002 Apr;26(4):537-45. doi: 10.1016/S0893-133X(01)00387-6. Neuropsychopharmacology. 2002. PMID: 11927178

4

Rehospitalization risk with second-generation and depot antipsychotics.

Conley RR, Kelly DL, Love RC, McMahon RP. Conley RR, et al. Among authors: kelly dl. Ann Clin Psychiatry. 2003 Mar;15(1):23-31. doi: 10.1023/a:1023276509470. Ann Clin Psychiatry. 2003. PMID: 12839430

5

Atypical antipsychotic use in a state hospital inpatient adolescent population.

Kelly DL, Love RC, MacKowick M, McMahon RP, Conley RR. Kelly DL, et al. J Child Adolesc Psychopharmacol. 2004 Spring;14(1):75-85. doi: 10.1089/104454604773840517. J Child Adolesc Psychopharmacol. 2004. PMID: 15142394

6

Lifetime psychiatric symptoms in persons with schizophrenia who died by suicide compared to other means of death.

Kelly DL, Shim JC, Feldman SM, Yu Y, Conley RR. Kelly DL, et al. J Psychiatr Res. 2004 Sep-Oct;38(5):531-6. doi: 10.1016/j.jpsychires.2004.02.001. J Psychiatr Res. 2004. PMID: 15380404

7

Comparison of clozapine use in Maryland and in Victoria, Australia.

Conley RR, Kelly DL, Lambert TJ, Love RC. Conley RR, et al. Among authors: kelly dl. Psychiatr Serv. 2005 Mar;56(3):320-3. doi: 10.1176/appi.ps.56.3.320. Psychiatr Serv. 2005. PMID: 15746507

8

Risperidone, quetiapine, and fluphenazine in the treatment of patients with therapy-refractory schizophrenia.

Conley RR, Kelly DL, Nelson MW, Richardson CM, Feldman S, Benham R, Steiner P, Yu Y, Khan I, McMullen R, Gale E, Mackowick M, Love RC. Conley RR, et al. Among authors: kelly dl. Clin Neuropharmacol. 2005 Jul-Aug;28(4):163-8. doi: 10.1097/01.wnf.0000172993.89879.0f. Clin Neuropharmacol. 2005. PMID: 16062094 Clinical Trial.

9

Cardiovascular disease in relation to weight in deceased persons with schizophrenia.

Conley RR, Shim JC, Kelly DL, Feldman S, Yu Y, McMahon RP. Conley RR, et al. Among authors: kelly dl. Compr Psychiatry. 2005 Nov-Dec;46(6):460-7. doi: 10.1016/j.comppsych.2005.03.007. Compr Psychiatry. 2005. PMID: 16275214

10

Adjunct divalproex or lithium to clozapine in treatment-resistant schizophrenia.

Kelly DL, Conley RR, Feldman S, Yu Y, McMahon RP, Richardson CM. Kelly DL, et al. Psychiatr Q. 2006 Spring;77(1):81-95. doi: 10.1007/s11126-006-7963-9. Psychiatr Q. 2006. PMID: 16397757

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

426 results

Search Page

Filters